Performance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery

PURPOSE: Safe breast cancer lumpectomies require microscopically clear margins. Real-time margin assessment options are limited, and 20–40% of lumpectomies have positive margins requiring re-excision. The LUM Imaging System previously showed excellent sensitivity and specificity for tumor detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanahan, Conor R., Kelly, Bridget N., Gadd, Michele A., Specht, Michelle C., Brown, Carson L., Hughes, Kevin S., Tang, Rong, Rai, Upahvan, Brachtel, Elena F., Rice-Stitt, Travis, Smith, Barbara L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062324/
https://www.ncbi.nlm.nih.gov/pubmed/33611664
http://dx.doi.org/10.1007/s10549-021-06106-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062324/
https://www.ncbi.nlm.nih.gov/pubmed/33611664
http://dx.doi.org/10.1007/s10549-021-06106-w

Ejemplares similares